Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (5675)	5/6/2000 3:04:00 PM
From: Ben Wa	Read Replies (1) \| Respond to of 5736

WASHINGTON, April 18 (Reuters) - Chromatics Color Sciences International Inc. (NASDAQ: CCSI) filed on Tuesday to sell from time to time up to 1 million common shares, which are valued at $5 million based on Monday's close of $5 on Nasdaq. The New York City-based company, whose ColorMate system is used to classify the color of human tissue, fluid, hair and/or teeth, plans to use the net proceeds for product development and capital expenditures. It also plans to use the money for sales and marketing and other general corporate purposes, according to a shelf registration filing with the Securities and Exchange Commission. A shelf registration gives a company advance SEC approval to sell securities, allowing the company flexibility in the amount and timing of an offering. The filing did not say how many total outstanding common shares the company will have after the offering. The ColorMate system is also used to monitor infant jaundice. Janybird - please explain what this is for. thank you in advance.